177 related articles for article (PubMed ID: 38539500)
1. Exploratory Assessment of Galectin-1, -3, and -9 in Non-Small Cell Lung Cancer.
Shuster H; Funkhouser A; Allen L; Heo M; Martin JC; Edenfield WJ; Blenda AV
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539500
[TBL] [Abstract][Full Text] [Related]
2. [Expression and Clinical Significance of Galcetin-3 in the Serum of Non-small Cell Lung Cancer Patients].
Qi D; Zhang Y; Li H; Wang R; Qian K
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):333-336. PubMed ID: 32429635
[TBL] [Abstract][Full Text] [Related]
3. Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.
Schulkens IA; Heusschen R; van den Boogaart V; van Suylen RJ; Dingemans AM; Griffioen AW; Thijssen VL
PLoS One; 2014; 9(9):e107988. PubMed ID: 25259711
[TBL] [Abstract][Full Text] [Related]
4. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
5. Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer.
Blair BB; Funkhouser AT; Goodwin JL; Strigenz AM; Chaballout BH; Martin JC; Arthur CM; Funk CR; Edenfield WJ; Blenda AV
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638303
[TBL] [Abstract][Full Text] [Related]
6. Galectin-9 in non-small cell lung cancer.
He Y; Jia K; Dziadziuszko R; Zhao S; Zhang X; Deng J; Wang H; Hirsch FR; Zhou C
Lung Cancer; 2019 Oct; 136():80-85. PubMed ID: 31454748
[TBL] [Abstract][Full Text] [Related]
7. The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer.
Terzioğlu-Uşak Ş; Horozoğlu C; Demirkol Ş; Turna A; Yaylım İ
Turk Gogus Kalp Damar Cerrahisi Derg; 2021 Apr; 29(2):212-222. PubMed ID: 34104515
[TBL] [Abstract][Full Text] [Related]
8. Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer.
Funkhouser A; Shuster H; Martin JC; Edenfield WJ; Blenda AV
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568625
[TBL] [Abstract][Full Text] [Related]
9. Predictive importance of galectin-3 for recurrence of non-small cell lung cancer.
Kataoka Y; Igarashi T; Ohshio Y; Fujita T; Hanaoka J
Gen Thorac Cardiovasc Surg; 2019 Aug; 67(8):704-711. PubMed ID: 30903521
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy.
Kusuhara S; Igawa S; Ichinoe M; Nagashio R; Kuchitsu Y; Hiyoshi Y; Shiomi K; Murakumo Y; Saegusa M; Satoh Y; Sato Y; Naoki K
Thorac Cancer; 2021 May; 12(10):1570-1578. PubMed ID: 33793071
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
[TBL] [Abstract][Full Text] [Related]
13.
Funkhouser AT; Strigenz AM; Blair BB; Miller AP; Shealy JC; Ewing JA; Martin JC; Funk CR; Edenfield WJ; Blenda AV
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681762
[TBL] [Abstract][Full Text] [Related]
14. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.
Jeong SH; Lee HW; Han JH; Kang SY; Choi JH; Jung YM; Choi H; Oh YT; Park KJ; Hwang SC; Sheen SS; Oh YJ; Kim JH; Lim HY
Jpn J Clin Oncol; 2008 Oct; 38(10):661-9. PubMed ID: 18772168
[TBL] [Abstract][Full Text] [Related]
15. The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
Szöke T; Kayser K; Trojan I; Kayser G; Furak J; Tiszlavicz L; Baumhäkel JD; Gabius HJ
Eur J Cardiothorac Surg; 2007 May; 31(5):783-7. PubMed ID: 17369045
[TBL] [Abstract][Full Text] [Related]
16. Predictive role of galectin-3 for immune checkpoint blockades (ICBs) in advanced or metastatic non-small cell lung cancer: a potential new marker for ICB resistance.
Kim JS; Kim S; Koh J; Kim M; Keam B; Kim TM; Lindmark B; Kim DW
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2355-2365. PubMed ID: 35976444
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis.
Sun Q; Zhang Y; Liu M; Ye Z; Yu X; Xu X; Qin Y
Cancer Cell Int; 2019; 19():309. PubMed ID: 31832021
[TBL] [Abstract][Full Text] [Related]
18. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer.
Szoke T; Kayser K; Baumhakel JD; Trojan I; Furak J; Tiszlavicz L; Horvath A; Szluha K; Gabius HJ; Andre S
Oncology; 2005; 69(2):167-74. PubMed ID: 16127288
[TBL] [Abstract][Full Text] [Related]
20. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
